Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Vaccinex Inc |
24/04 | 5,005 USD
+0,84% |
+0,84% |
Valbiotis SA |
24/04 | 3,930 EUR
+0,13% |
+0,13% |
|
Valneva SE |
24/04 | 3,588 EUR
-3,55% |
-3,55% |
|
Vanda Pharmaceuticals Inc |
24/04 | 4,560 USD
-1,51% |
-1,51% |
|
Vapotherm Inc |
23/04 | 1,266 USD
+0,48% |
+0,48% |
|
Varex Imaging Corp |
24/04 | 17,080 USD
-1,10% |
-1,10% |
|
Vascular Biogenics Ltd |
16/10 | 0,156 USD
-8,77% |
-8,77% |
|
Vaxart Inc |
24/04 | 0,710 USD
-4,79% |
-4,79% |
|
Vaxcyte Inc |
24/04 | 60,300 USD
-0,95% |
-0,95% |
|
VBI Vaccines Inc. |
24/04 | 0,590 USD
-3,04% |
-3,04% |
Ventripoint Diagnostics Ltd |
24/04 | 0,210 CAD
-4,55% |
-4,55% |
Venture Life Group Plc |
24/04 | 42,000 GBX
+3,70% |
+3,70% |
|
Venus Concept Inc |
24/04 | 0,721 USD
-5,14% |
-5,14% |
|
Veracyte Inc |
24/04 | 19,900 USD
+0,35% |
+0,35% |
|
Verastem Inc |
24/04 | 9,310 USD
-3,12% |
-3,12% |
|
Vericel Corp |
24/04 | 46,110 USD
-0,67% |
-0,67% |
|
Verona Pharma Plc |
24/04 | 15,240 USD
-2,25% |
-2,25% |
|
Verrica Pharmaceuticals Inc |
24/04 | 6,790 USD
-0,88% |
-0,88% |
|
Vertex Pharmaceuticals, Inc. |
24/04 | 400,760 USD
-1,02% |
-1,02% |
|
Veru Inc |
24/04 | 1,320 USD
+3,53% |
+3,53% |
|
Vetoquinol |
24/04 | 99,900 EUR
+1,01% |
+1,01% |
|
Viatris Inc |
24/04 | 11,550 USD
+1,67% |
+1,67% |
|
ViewRay Inc. |
4/04 | 0,025 USD
0,00% |
0,00% |
|
Viking Therapeutics Inc |
24/04 | 65,070 USD
+0,22% |
+0,22% |
|
Vir Biotechnology Inc |
24/04 | 8,040 USD
-1,11% |
-1,11% |
|
Virbac SA |
24/04 | 360,000 EUR
+0,28% |
+0,28% |
|
Visiomed Group |
24/04 | 0,187 EUR
-4,29% |
-4,29% |
|
VistaGen Therapeutics Inc |
24/04 | 4,720 USD
-2,28% |
-2,28% |
Vita 34 AG |
24/04 | 5,000 EUR
-0,99% |
-0,99% |
|
Vivakor Inc |
24/04 | 1,500 USD
+1,35% |
+1,35% |
|
Viveve Medical Inc |
24/04 | 0,000 USD
0,00% |
0,00% |
Vivoryon Therapeutics |
24/04 | 0,895 EUR
+24,31% |
+24,31% |
|
VolitionRX Ltd |
24/04 | 0,800 USD
-5,88% |
-5,88% |
|
Voyager Therapeutics Inc |
24/04 | 7,570 USD
-1,05% |
-1,05% |
|
vTv Therapeutics Inc |
24/04 | 25,500 USD
+2,10% |
+2,10% |
|
VYNE Therapeutics Inc |
24/04 | 2,570 USD
+10,78% |
+10,78% |